India records first Omicron death after Rajasthan man with comorbidities succumbs
The 73-year-old man, who was found infected with Omicron in genome sequencing and who had tested negative for the infection twice, died in a Udaipur hospital on 31 December, said the Union health ministry
Representational image. PTI
New Delhi: India on Wednesday recorded the first death linked to the Omicron variant of the coronavirus after the samples of a man in Rajasthan's Udaipur, who died last week, showed the presence of the variant, sources in the Union health ministry said.
The 73-year-old man, who was found infected with Omicron in genome sequencing and who had tested negative for the infection twice, died in a Udaipur hospital on 31 December, they added.
He died due to post-Covid pneumonia coupled with comorbidities - diabetes mellitus, hypertension and hypothyroidism - Udaipur Chief Medical Health Officer (CMHO) Dr Dinesh Kharadi had said.
The man was found COVID-19 positive on 15 December and had symptoms like fever, cough and rhinitis and therefore, was admitted to the hospital.
A sample was sent for genome sequencing and the results were received on 25 December, in which he was found infected with the Omicron variant of the virus. The man had tested negative for COVID-19 twice on 21 and 25 December.
also read
India logs 7,145 new COVID-19 cases, 289 deaths in last 24 hours; active infections decline to 84,565
The daily rise in new coronavirus infections has been recorded below 15,000 for the last 51 days now.
From setting up testing wards to new SOPs, here's what states are doing amid Omicron fears
With fresh COVID concerns, Karnataka's Basvaraj Bommai said the government is closely monitoring the situation in the state and will take decisions on enforcing further containment measures after consulting the experts.
Early data of COVID-19 vaccine booster to tackle multiple variants shows promise
The yet-to-be peer-reviewed results also show the vaccine, being trialled with the anticipated involvement of 20 people aged 60 and over, was generally safe and well-tolerated.